NSE › Healthcare

Lupin Limited (LUPIN)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹2,393.00-0.91%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

₹7,475 cr

Revenue YoY

+31.9%

Net profit

₹1,460 cr

Profit YoY

+89.0%

EPS

₹34.75

EPS estimate

₹27.93

Net margin

19.5%

EPS came in at 34.75 against a street estimate of 27.93 — a beat of 24.4%.

Key statistics

Market cap

₹1.10 lakh cr

P/E

20.7

Forward P/E

18.1

P/B

4.92

Book value

₹491.02

EPS (TTM)

₹116.40

Dividend yield

0.74%

52-week high

₹2,523.70

52-week low

₹1,823.58

50-day MA

₹2,368.96

200-day MA

₹2,238.32

Beta

0.18

Analyst view

with an average price target of ₹2,488.68.

Shareholding

Promoters

47.02%

Institutions

34.71%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Lupin Limited — free to start.

Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Cipla Limited Zydus Lifesciences Limited Max Healthcare Institute Limited Mankind Pharma Ltd Laurus Labs Limited Lenskart Solutions Ltd Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited

Data updated 2026-08-05.